{"id":"NCT02200614","sponsor":"Bayer","briefTitle":"Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer","officialTitle":"A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09-12","primaryCompletion":"2018-09-03","completion":"2021-06-14","firstPosted":"2014-07-25","resultsPosted":"2019-10-29","lastUpdate":"2022-06-28"},"enrollment":1509,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer Non-Metastatic","Castration-Resistant"],"interventions":[{"type":"DRUG","name":"Darolutamide (Nubeqa, BAY1841788)","otherNames":["ODM-201"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Darolutamide (BAY1841788)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.","primaryOutcome":{"measure":"Metastasis-Free Survival","timeFrame":"From randomization to the time approximately 385 MFS events were observed (approximately 48 months)","effectByArm":[{"arm":"Darolutamide (BAY1841788)","deltaMin":40.37,"sd":null},{"arm":"Placebo","deltaMin":18.43,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.000001"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":18},"locations":{"siteCount":404,"countries":["United States","Argentina","Australia","Austria","Belarus","Belgium","Brazil","Bulgaria","Canada","Colombia","Czechia","Estonia","Finland","France","Germany","Hungary","Israel","Italy","Japan","Latvia","Lithuania","Peru","Poland","Portugal","Romania","Russia","Serbia","Slovakia","South Africa","South Korea","Spain","Sweden","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["40132221","38394384","37660438","37222151","36087070","34797506","33554636","32905676","31571095","30763142"],"seeAlso":["http://www.clinicaltrialsregister.eu/","http://clinicaltrials.bayer.com/"]},"adverseEventsSummary":{"seriousAny":{"events":251,"n":954},"commonTop":["Fatigue","Arthralgia","Back pain","Diarrhoea","Constipation"]}}